Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2007
04/12/2007WO2007040162A1 Process for producing recombinant human thrombin by cultured cell
04/12/2007WO2007040123A1 Method for detection of human precursor t cell and precursor b cell
04/12/2007WO2007040118A1 Chip provided with film having hole pattern with the use of thermoresponsive polymer and method of producing the same
04/12/2007WO2007040105A1 Method for production of t cell population
04/12/2007WO2007039986A1 Method of obtaining pancreatic endocrine cells from adipose tissue-origin cells
04/12/2007WO2007039973A1 Reinforcing agent for biological tissue, method of producing the same, utilization of the same and method of culturing cells
04/12/2007WO2007039726A1 Reactor comprising an annular reaction space
04/12/2007WO2007039662A2 Vero cell line which is adapted to grow in suspension, method of obtaining same and viral vaccines
04/12/2007WO2007039489A1 Antibodies against april as biomarkers for early prognosis of lymphoma patients
04/12/2007WO2007039316A1 Improved methods and means for producings hyaluronan
04/12/2007WO2007039258A1 Use of a cellular extract for a mitotic remodeling of chromosomes
04/12/2007WO2007039216A1 Phenyl-(4-phenyl-pyrimidin-2-yl)-amines for enhancing immunotolerance
04/12/2007WO2007039150A2 Cell populations having immunoregulatory activity, method for isolation and uses
04/12/2007WO2007038933A2 A method for producing cells with efficient engraftment within the heart
04/12/2007WO2007038854A1 Method of culturing conifer somatic embryos using s(+)-abscisic acid
04/12/2007WO2007014639A3 Method for isolating stem cells from cryopreserved dental tissue
04/12/2007WO2007011845A3 Use of a bacillus meti gene to improve methionine production in microorganisms
04/12/2007WO2007000523A3 Epigenetic and genetic treatment method and system
04/12/2007WO2006138718A3 Three-dimensional scaffolds for tissue engineering made by processing complex extracts of natural extracellular matrices
04/12/2007WO2006134017A3 Modulation of cells
04/12/2007WO2006125068A3 Production of enzymes
04/12/2007WO2006113181A3 Stem-like cells in bone sarcomas
04/12/2007WO2006102901A3 Immunogenic egfr peptides comprising foreign t cell stimulating epitope
04/12/2007WO2006097110A3 Polypeptides having antimicrobial activity and polynucleotides encoding same
04/12/2007WO2006093860A3 Method and composition for repairing heart tissue
04/12/2007WO2006083671B1 Bacterial glycolipid activation of cd1d-restricted nkt cells
04/12/2007WO2006071903A3 Cell based methods and systems for the identification of rna regulatory sequences and compounds that modulate their functions
04/12/2007WO2006053246A3 A new sos 1 gene from halophila that confers salt tolerance
04/12/2007WO2006050138A3 Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use
04/12/2007WO2005107796A3 Cellular permissivity factor for viruses, and uses thereof
04/12/2007WO2004072268A3 Pkhdl1, a homolog of the autosomal recessive kidney disease gene
04/12/2007WO2002086079A3 T1r3 a novel taste receptor
04/12/2007US20070083952 Recombinant DNA constructs and methods for controlling gene expression
04/12/2007US20070083951 Recombinant DNA constructs and methods for controlling gene expression
04/12/2007US20070083950 Recombinant DNA constructs and methods for controlling gene expression
04/12/2007US20070083949 Recombinant DNA constructs and methods for controlling gene expression
04/12/2007US20070083948 Method and composition for increasing branching and flowering response in plants
04/12/2007US20070083946 Recombinant watermelon (Citrullus lanatus) hydroperoxide lyase and uses thereof
04/12/2007US20070083941 Rat TRPM7 polynucleotide and encoded protein
04/12/2007US20070083940 Transformed silkworm producing human collagen
04/12/2007US20070082866 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
04/12/2007US20070082863 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds
04/12/2007US20070082847 Variants of vascular endothelial cell growth factor, their uses, and processes for their production
04/12/2007US20070082846 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
04/12/2007US20070082400 signaling cells with an interferon gamma receptor agonists and tumor necrosis factor agonists, then with a second signal comprising a CD40 agonist and natural killer cells, to produce chemokine receptor (CCR7) mature cells, used as immunostimulants
04/12/2007US20070082399 Compositions and method for stable isotope labelling of biological compounds
04/12/2007US20070082398 Self-contained cell culture apparatus and method of use
04/12/2007US20070082397 Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs
04/12/2007US20070082396 Eleminating myoglobin from blood using iv filter
04/12/2007US20070082395 Production of normal human osteoclasts
04/12/2007US20070082394 Cell culture media, kits and methods of use
04/12/2007US20070082393 Polymer coated nanofibrillar structures and methods for cell maintenance and differentiation
04/12/2007US20070082392 modified erythrocytes of the present invention comprise CD4 and at least one HIV coreceptor, such as CXCR4 or CCR5. The modified erythrocytes, when administered to an HIV patient, bind to the plasma virus and induce the injection of the HIV ribonucleoprotein complex into the cells
04/12/2007US20070082382 Development of human monoclonal antibodies and uses thereof
04/12/2007US20070082380 Nucleic acids encoding and methods of producing fusion proteins
04/12/2007US20070082379 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis
04/12/2007US20070082368 Human cell clones useful for functional analyses of the biological activity of an endogeneous urotensin II receptor and uses thereof
04/12/2007US20070082367 Methods of purifying anti a beta antibodies
04/12/2007US20070082364 Antibody and use thereof
04/12/2007US20070082341 Human phospholipases
04/12/2007US20070082335 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction
04/12/2007US20070082333 Thermophilic dna polymerases from thermoactinomyces vulgaris
04/12/2007US20070082328 Rotatable time varying electromagnetic force bioreactor and method of using the same
04/12/2007US20070082327 Cellular phenotype
04/12/2007US20070082043 Liposomal vaccine
04/12/2007US20070082007 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
04/12/2007US20070082006 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
04/12/2007US20070082002 Neutralizing High Affinity Human Monoclonal Antibodies Specific to RSV F-Protein and Methods for their Manufacture and Therapeutic use thereof
04/12/2007US20070081995 Methods and compositions for targeting IFNAR2
04/12/2007US20070081983 Isolation of smooth muscle cells and tissue-engineered vasculature containing the isolated cells
04/12/2007US20070081981 Expanding population of human hematopoietic stem cells via reduction in activity of cyclin dependent kinases utilizing small RNA interfering; tissue regeneration
04/12/2007US20070081980 Culture cells from pancreatic islets
04/12/2007US20070081979 Multi-functional chimeric hematopoietic receptor agonists
04/12/2007US20070081973 Cytokine polypeptides
04/12/2007US20070081961 Extraction and use of collagen extracted from either a sea mammal or a bony fish
04/12/2007US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides
04/12/2007DE102004048462B4 Modellsystem zum Testen von pharmazeutischen Zubereitungen auf Wirksamkeit bei entzündlichen Prozessen im Nervensystem Model system to test pharmaceutical preparations for efficacy in inflammatory processes in the nervous system
04/12/2007CA2665080A1 Regulatable fusion promoters
04/12/2007CA2624973A1 Improved methods and means for producings hyaluronan
04/12/2007CA2624707A1 Method for selectively depleting hypoxic cells
04/12/2007CA2624144A1 Use of a cellular extract for a mitotic remodeling of chromosomes
04/12/2007CA2624072A1 Process for producing recombinant human thrombin by cultured cell
04/12/2007CA2623735A1 Method for production of t cell population
04/12/2007CA2623530A1 Antibodies against april as biomarkers for early prognosis of lymphoma patients
04/12/2007CA2623353A1 Cell populations having immunoregulatory activity, method for isolation and uses
04/12/2007CA2621326A1 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target
04/11/2007EP1772519A1 RNA binding protein and binding site useful for expression of recombinant molecules
04/11/2007EP1772517A2 DSP-3 dual specificity phosphatase
04/11/2007EP1772515A1 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR)
04/11/2007EP1772514A2 Manipulation of tissue or organ type using the notch pathway
04/11/2007EP1772052A1 Improved methods and means for production of hyaluronic acid
04/11/2007EP1771581A2 Functional variant of lymphoid tyrosine phosphatase is associated with autoimmune disorders
04/11/2007EP1771554A2 Microbially expressed xylanases and their use as feed additives and other uses
04/11/2007EP1771551A2 Novel cell populations and uses thereof
04/11/2007EP1771550A2 Isolated muscle satellite cells, use thereof in muscle tissue repair and method for isolating said muscle satellite cells
04/11/2007EP1771549A2 Method for isolating and culturing stem cells
04/11/2007EP1771548A1 Use of dendrimers to stimulate cell growth
04/11/2007EP1771547A1 P1-35 expression units
04/11/2007EP1771481A2 Novel anti-igf-ir antibodies and uses thereof
04/11/2007EP1771471A2 Genetically modified human natural killer cell lines